For people with diabetes, blood glucose levels may rise significantly, potentially requiring adjustment of diabetes medications
An analysis published this week in JAMA Internal Medicine found that most participants in a clinical trial who were assigned to stop taking tirzepatide (Zepbound from Eli Lilly) not only regained significant amounts of the weight they had lost on the drug, but they also saw their cardiovascular and metabolic improvements slip away
Nutrients, 16(3), 1203
The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study
Quality, purity, and accurate labelling can vary significantly between manufacturers
In contrast, the aging factor was up-regulated, suggesting that reducing IGF-1 may result in the aging of chondrocytes [37]